ICU Medical, Inc. (ICUI)
USD 154.07
(-1.97%)
USD 154.07
(-1.97%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 709.36 Million USD | 1.92% |
| 2022 | 696 Million USD | 139.81% |
| 2021 | 290.23 Million USD | -7.84% |
| 2020 | 314.92 Million USD | -6.73% |
| 2019 | 337.64 Million USD | 8.51% |
| 2018 | 311.16 Million USD | 7.8% |
| 2017 | 288.65 Million USD | 485.94% |
| 2016 | 49.26 Million USD | 12.91% |
| 2015 | 43.63 Million USD | 18.14% |
| 2014 | 36.93 Million USD | 7.2% |
| 2013 | 34.45 Million USD | -5.18% |
| 2012 | 36.33 Million USD | -10.12% |
| 2011 | 40.42 Million USD | -8.25% |
| 2010 | 44.05 Million USD | 6.6% |
| 2009 | 41.32 Million USD | 130.49% |
| 2008 | 17.93 Million USD | -8.07% |
| 2007 | 19.5 Million USD | 19.55% |
| 2006 | 16.31 Million USD | 5.7% |
| 2005 | 15.43 Million USD | 83.12% |
| 2004 | 8.42 Million USD | 148.06% |
| 2003 | 3.39 Million USD | -40.89% |
| 2002 | 5.74 Million USD | 260.66% |
| 2001 | 1.59 Million USD | 11.08% |
| 2000 | 1.43 Million USD | -31.67% |
| 1999 | 2.1 Million USD | 5.0% |
| 1998 | 2 Million USD | 11.11% |
| 1997 | 1.8 Million USD | -18.18% |
| 1996 | 2.2 Million USD | 46.67% |
| 1995 | 1.5 Million USD | -48.28% |
| 1994 | 2.9 Million USD | 141.67% |
| 1993 | 1.2 Million USD | 100.0% |
| 1992 | 600 Thousand USD | 50.0% |
| 1991 | 400 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 693 Million USD | -2.31% |
| 2024 Q2 | 682.87 Million USD | -1.46% |
| 2023 FY | 709.36 Million USD | 1.92% |
| 2023 Q4 | 709.36 Million USD | -6.62% |
| 2023 Q3 | 759.62 Million USD | -2.02% |
| 2023 Q2 | 775.26 Million USD | 3.65% |
| 2023 Q1 | 747.96 Million USD | 7.46% |
| 2022 Q4 | 696 Million USD | 11.31% |
| 2022 Q3 | 625.26 Million USD | 7.24% |
| 2022 Q1 | 536.31 Million USD | 84.79% |
| 2022 FY | 696 Million USD | 139.81% |
| 2022 Q2 | 583.05 Million USD | 8.71% |
| 2021 FY | 290.23 Million USD | -7.84% |
| 2021 Q2 | 299.61 Million USD | -0.16% |
| 2021 Q3 | 291.6 Million USD | -2.67% |
| 2021 Q4 | 290.23 Million USD | -0.47% |
| 2021 Q1 | 300.08 Million USD | -4.71% |
| 2020 Q3 | 321.96 Million USD | -0.25% |
| 2020 Q1 | 311.6 Million USD | -7.71% |
| 2020 Q2 | 322.76 Million USD | 3.58% |
| 2020 FY | 314.92 Million USD | -6.73% |
| 2020 Q4 | 314.92 Million USD | -2.18% |
| 2019 Q3 | 343.71 Million USD | 4.17% |
| 2019 Q4 | 337.64 Million USD | -1.77% |
| 2019 Q1 | 321.74 Million USD | 3.4% |
| 2019 Q2 | 329.95 Million USD | 2.55% |
| 2019 FY | 337.64 Million USD | 8.51% |
| 2018 FY | 311.16 Million USD | 7.8% |
| 2018 Q1 | 295.54 Million USD | 2.39% |
| 2018 Q3 | 291.84 Million USD | 1.0% |
| 2018 Q2 | 288.95 Million USD | -2.23% |
| 2018 Q4 | 311.16 Million USD | 6.62% |
| 2017 Q3 | 320.34 Million USD | -20.18% |
| 2017 Q2 | 401.31 Million USD | -9.96% |
| 2017 FY | 288.65 Million USD | 485.94% |
| 2017 Q4 | 288.65 Million USD | -9.89% |
| 2017 Q1 | 445.68 Million USD | 804.68% |
| 2016 Q4 | 49.26 Million USD | -3.31% |
| 2016 Q3 | 50.95 Million USD | 2.07% |
| 2016 FY | 49.26 Million USD | 12.91% |
| 2016 Q1 | 49.24 Million USD | 12.85% |
| 2016 Q2 | 49.91 Million USD | 1.38% |
| 2015 Q4 | 43.63 Million USD | 7.25% |
| 2015 Q1 | 37.66 Million USD | 1.97% |
| 2015 Q2 | 38.23 Million USD | 1.52% |
| 2015 FY | 43.63 Million USD | 18.14% |
| 2015 Q3 | 40.68 Million USD | 6.41% |
| 2014 FY | 36.93 Million USD | 7.2% |
| 2014 Q4 | 36.93 Million USD | -3.44% |
| 2014 Q3 | 38.24 Million USD | 1.13% |
| 2014 Q1 | 36.68 Million USD | 6.49% |
| 2014 Q2 | 37.81 Million USD | 3.09% |
| 2013 Q3 | 34.15 Million USD | -5.87% |
| 2013 Q2 | 36.28 Million USD | -0.71% |
| 2013 Q1 | 36.54 Million USD | 0.57% |
| 2013 Q4 | 34.45 Million USD | 0.87% |
| 2013 FY | 34.45 Million USD | -5.18% |
| 2012 FY | 36.33 Million USD | -10.12% |
| 2012 Q4 | 36.33 Million USD | -3.34% |
| 2012 Q3 | 37.58 Million USD | 2.88% |
| 2012 Q2 | 36.53 Million USD | -2.02% |
| 2012 Q1 | 37.29 Million USD | -7.75% |
| 2011 Q4 | 40.42 Million USD | -6.78% |
| 2011 FY | 40.42 Million USD | -8.25% |
| 2011 Q1 | 51.19 Million USD | 16.21% |
| 2011 Q2 | 49.37 Million USD | -3.57% |
| 2011 Q3 | 43.36 Million USD | -12.17% |
| 2010 Q4 | 44.05 Million USD | 0.99% |
| 2010 Q3 | 43.62 Million USD | 5.99% |
| 2010 Q2 | 41.15 Million USD | 9.59% |
| 2010 Q1 | 37.55 Million USD | -9.12% |
| 2010 FY | 44.05 Million USD | 6.6% |
| 2009 Q4 | 41.32 Million USD | -8.04% |
| 2009 Q3 | 44.94 Million USD | 81.57% |
| 2009 FY | 41.32 Million USD | 130.49% |
| 2009 Q2 | 24.75 Million USD | 14.09% |
| 2009 Q1 | 21.69 Million USD | 21.0% |
| 2008 Q3 | 19.15 Million USD | -7.06% |
| 2008 Q2 | 20.61 Million USD | -3.12% |
| 2008 Q4 | 17.93 Million USD | -6.4% |
| 2008 FY | 17.93 Million USD | -8.07% |
| 2008 Q1 | 21.27 Million USD | 9.08% |
| 2007 Q2 | 15.74 Million USD | -2.66% |
| 2007 Q4 | 19.5 Million USD | 10.19% |
| 2007 FY | 19.5 Million USD | 19.55% |
| 2007 Q1 | 16.17 Million USD | -0.85% |
| 2007 Q3 | 17.7 Million USD | 12.41% |
| 2006 FY | 16.31 Million USD | 5.7% |
| 2006 Q4 | 16.31 Million USD | -15.78% |
| 2006 Q1 | 16.66 Million USD | 7.96% |
| 2006 Q2 | 18.54 Million USD | 11.31% |
| 2006 Q3 | 19.37 Million USD | 4.43% |
| 2005 Q1 | 7.37 Million USD | -12.53% |
| 2005 Q3 | 13.53 Million USD | -16.72% |
| 2005 Q4 | 15.43 Million USD | 14.06% |
| 2005 FY | 15.43 Million USD | 83.12% |
| 2005 Q2 | 16.24 Million USD | 120.37% |
| 2004 FY | 8.42 Million USD | 148.06% |
| 2004 Q4 | 8.42 Million USD | -11.8% |
| 2004 Q3 | 9.55 Million USD | 1.63% |
| 2004 Q2 | 9.4 Million USD | 59.12% |
| 2004 Q1 | 5.91 Million USD | 73.93% |
| 2003 Q1 | 4.37 Million USD | -23.85% |
| 2003 Q4 | 3.39 Million USD | -27.39% |
| 2003 FY | 3.39 Million USD | -40.89% |
| 2003 Q3 | 4.68 Million USD | -35.6% |
| 2003 Q2 | 7.26 Million USD | 65.99% |
| 2002 FY | 5.74 Million USD | 260.66% |
| 2002 Q4 | 5.74 Million USD | 7.94% |
| 2002 Q3 | 5.32 Million USD | 56.69% |
| 2002 Q2 | 3.39 Million USD | 107.38% |
| 2002 Q1 | 1.63 Million USD | 2.82% |
| 2001 Q1 | 1.6 Million USD | 11.92% |
| 2001 Q4 | 1.59 Million USD | -33.89% |
| 2001 FY | 1.59 Million USD | 11.08% |
| 2001 Q3 | 2.41 Million USD | 2.95% |
| 2001 Q2 | 2.34 Million USD | 45.83% |
| 2000 FY | 1.43 Million USD | -31.67% |
| 2000 Q4 | 1.43 Million USD | 18.69% |
| 2000 Q3 | 1.2 Million USD | 36.15% |
| 2000 Q2 | 888 Thousand USD | -33.28% |
| 2000 Q1 | 1.33 Million USD | -36.62% |
| 1999 Q4 | 2.1 Million USD | 16.67% |
| 1999 Q1 | 2.4 Million USD | 20.0% |
| 1999 Q3 | 1.8 Million USD | -10.0% |
| 1999 FY | 2.1 Million USD | 5.0% |
| 1999 Q2 | 2 Million USD | -16.67% |
| 1998 Q3 | 2.4 Million USD | 9.09% |
| 1998 FY | 2 Million USD | 11.11% |
| 1998 Q1 | 2 Million USD | 11.11% |
| 1998 Q2 | 2.2 Million USD | 10.0% |
| 1998 Q4 | 2 Million USD | -16.67% |
| 1997 Q3 | 1.7 Million USD | -22.73% |
| 1997 Q1 | 2.2 Million USD | 0.0% |
| 1997 Q4 | 1.8 Million USD | 5.88% |
| 1997 Q2 | 2.2 Million USD | 0.0% |
| 1997 FY | 1.8 Million USD | -18.18% |
| 1996 Q1 | 2 Million USD | 33.33% |
| 1996 Q2 | 2 Million USD | 0.0% |
| 1996 Q3 | 1.9 Million USD | -5.0% |
| 1996 FY | 2.2 Million USD | 46.67% |
| 1996 Q4 | 2.2 Million USD | 15.79% |
| 1995 Q2 | 2 Million USD | -20.0% |
| 1995 Q1 | 2.5 Million USD | -13.79% |
| 1995 FY | 1.5 Million USD | -48.28% |
| 1995 Q4 | 1.5 Million USD | -11.76% |
| 1995 Q3 | 1.7 Million USD | -15.0% |
| 1994 Q2 | 1.8 Million USD | 12.5% |
| 1994 FY | 2.9 Million USD | 141.67% |
| 1994 Q1 | 1.6 Million USD | 33.33% |
| 1994 Q3 | 2.6 Million USD | 44.44% |
| 1994 Q4 | 2.9 Million USD | 11.54% |
| 1993 Q1 | 700 Thousand USD | 16.67% |
| 1993 Q2 | 1.1 Million USD | 57.14% |
| 1993 Q3 | 700 Thousand USD | -36.36% |
| 1993 Q4 | 1.2 Million USD | 71.43% |
| 1993 FY | 1.2 Million USD | 100.0% |
| 1992 FY | 600 Thousand USD | 50.0% |
| 1992 Q1 | 400 Thousand USD | 0.0% |
| 1992 Q4 | 600 Thousand USD | -14.29% |
| 1992 Q2 | 700 Thousand USD | 75.0% |
| 1992 Q3 | 700 Thousand USD | 0.0% |
| 1991 Q4 | 400 Thousand USD | 0.0% |
| 1991 FY | 400 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -3868.004% |
| AngioDynamics, Inc. | 60.61 Million USD | -1070.252% |
| AtriCure, Inc. | 67.89 Million USD | -944.759% |
| Avinger, Inc. | 5.29 Million USD | -13289.203% |
| Azenta, Inc. | 128.19 Million USD | -453.332% |
| BioLife Solutions, Inc. | 43.45 Million USD | -1532.364% |
| The Cooper Companies, Inc. | 735.6 Million USD | 3.567% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -13946.733% |
| Femasys Inc. | 667.11 Thousand USD | -106232.013% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -2770.044% |
| Hologic, Inc. | 679.8 Million USD | -4.348% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 41.884% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -20276.29% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | -1255.474% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -82695.745% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -82695.745% |
| Masimo Corporation | 545 Million USD | -30.158% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -43762.79% |
| Merit Medical Systems, Inc. | 303.87 Million USD | -133.441% |
| Nephros, Inc. | 2.47 Million USD | -28619.028% |
| NovoCure Limited | 38.15 Million USD | -1759.3% |
| NEXGEL, Inc. | 1.31 Million USD | -53680.136% |
| NEXGEL, Inc. | 1.31 Million USD | -53680.136% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -5126.643% |
| OraSure Technologies, Inc. | 47.61 Million USD | -1389.814% |
| Pro-Dex, Inc. | 15.26 Million USD | -4545.753% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -143386.51% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -24632.75% |
| QuidelOrtho Corporation | 577.8 Million USD | -22.769% |
| Repligen Corporation | 202.32 Million USD | -250.611% |
| Sanara MedTech Inc. | 4.71 Million USD | -14936.673% |
| STAAR Surgical Company | 35.13 Million USD | -1919.243% |
| Sharps Technology, Inc. | 1.7 Million USD | -41404.036% |
| Utah Medical Products, Inc. | 9.58 Million USD | -7303.047% |
| DENTSPLY SIRONA Inc. | 624 Million USD | -13.679% |
| Jin Medical International Ltd. | 5.05 Million USD | -13938.015% |